Man­u­fac­tur­ing roundup: An­de­lyn Bio­sciences opens new fa­cil­i­ty in Ohio; No­vo warns of Ozem­pic coun­ter­feit

An­de­lyn Bio­sciences, a cell and gene ther­a­py CD­MO, has opened a new man­u­fac­tur­ing head­quar­ters in Colum­bus, OH.

The new 180,000-square-foot fa­cil­i­ty is home to An­de­lyn …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.